Therefore, the 5-HT1A receptor agonist (buspirone or ipsapirone) challenge test has been used for the diagnosis of ME/CFS via measurement of prolactin or adrenocorticotropic hormone (ACTH) released from the hypothalamus [14, 50]. Here, POMC is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.